Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00374218
Other study ID # UTREB17491
Secondary ID
Status Completed
Phase Phase 2
First received September 8, 2006
Last updated August 13, 2007
Start date September 2006
Est. completion date April 2007

Study information

Verified date August 2007
Source University of Toronto
Contact n/a
Is FDA regulated No
Health authority Canada: Health Canada
Study type Interventional

Clinical Trial Summary

Weight gain is linked to a high consumption of soft-drinks and other beverages sweetened with high fructose corn syrup. Being overweight increases risk for diabetes and heart disease. These problems may be due to high blood glucose and insulin responses caused by high fructose corn syrup. Sucromalt is a sweetener which contains the same amount of carbohydrate at high fructose corn syrup, but causes lower glucose and insulin responses. The purpose of this study is to see if consuming soft-drinks and other foods sweetened with sucromalt instead of high fructose corn syrup will result in lower levels of blood glucose, insulin, cholesterol and other markers of risk. We are including in this study people who are overweight and normally consume soft-drinks because they are the ones most likely to benefit from this change.


Description:

Diets with a high glycemic load (GL) are associated with increased risk of diabetes and cardiovascular disease, possibly because of their association with the metabolic syndrome, dyslipidemia and increased markers of chronic inflammation. Since GL is the product of glycemic index (GI) times the amount of carbohydrate in the diet, GL can be reduced either by reducing GI or by reducing carbohydrate intake, and the effect of these maneuvers on health biomarkers may not necessarily be the same.

A high consumption of sugars in regular soft drinks has been associated with increased weight gain in adolescents, and, in adults, replacing starch with sucrose in the diet has been shown to result in weight gain and an increase in blood pressure and certain inflammatory markers. However, in the latter studies, the effects of sucrose in sucrose-sweetened beverages and foods were compared to those of aspartame-sweetened beverages and foods. Since aspartame contains no energy, the sucrose and control diets differed not only in sucrose, but also in energy, fat and protein; with more energy and less fat and protein as a % of energy on the sucrose than the control diet. This results in a problem in interpretation of the results because it is not possible to know what dietary change was responsible for the changes in biomarkers - indeed some changes due to increased sucrose intake may have been offset by opposite changes in, for example, saturated fat intake.

Another approach to studying the effect of reducing the GL of the diet is to reduce the GI of the diet without changing the amounts of energy, carbohydrate, fat or protein. Such an approach may be more scientifically desirable because it is possible to study the effect of changing only one dietary variable. Recently, the development of sucromalt allows the replacement of high fructose corn syrup (HFCS) in foods and beverages with a nutritive carbohydrate sweetener that has a reduced GI. Sucromalt is an enzymatically modified carbohydrate which we have shown elicits lower glucose and insulin responses than HFCS without apparent malabsorption. Therefore, the purpose of this study is to conduct a pilot study to see if exchanging HFCS with sucromalt has any effect on glucose tolerance and fasting blood lipids and inflammatory biomarkers in subjects with a high waist circumference.


Recruitment information / eligibility

Status Completed
Enrollment 28
Est. completion date April 2007
Est. primary completion date
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 20 Years to 50 Years
Eligibility Inclusion Criteria:

- males or non-pregnant and non-lactating females

- aged 20-50

- normally drink at least 2 cans (680ml) regular soft-drinks or sugar sweetened drinks per day

- high waist circumference (=102cm (40in) in men or =88cm (34.5in) in women)

Exclusion Criteria:

- Body mass index >35.0kg/m²

- Subjects whose weight is not stable (varied by >5% of current weight over the past 6 months).

- Subject who regularly undertake >30min vigorous physical activity per week.

- Diabetes based on current treatment with insulin or an oral hypoglycemic agent or fasting glucose =7.0mmol/L on screening

- Fasting triglycerides =10.0mmol/L

- Severe liver dysfunction (transaminase >180% of upper limit of normal)

- Severe renal impairment (serum creatinine >140% of upper limit of normal)

- Any major medical or surgical event within 6 months

- History of inflammatory bowel disease, malabsorption, or other disorder or drug use affecting gastrointestinal motility or the absorption of nutrients

- Use of drugs which affect glucose or lipids except: stable doses (3 months) of statins, fibrates, beta-blockers, diuretics.

- Substance abuse

- Simultaneous participation in another clinical trial

- Any other condition which, in the opinion of Dr. Wolever, might make the subject's participating harmful to him(her)self or others or affect the results

- Inability to understand spoken and written English

- Unwilling or unable to consume the test foods (drinks and nutrition bars) and/or to undergo the test procedures

- Unwilling or unable to give informed consent and/or sign the consent form

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double-Blind, Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Drug:
High Fructose Corn Syrup

Sucromalt


Locations

Country Name City State
Canada Glycemic Index Laboratories Toronto Ontario

Sponsors (1)

Lead Sponsor Collaborator
University of Toronto

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary Fasting and 2h glucose after 75g oral glucose tolerance test 4 weeks
Secondary Fasting and 2h insulin after 75g oral glucose 4 weeks
Secondary Gut hormone responses (eg. GLP-1) after 75g oral glucose 4 weeks
Secondary Postprandial glucose and insulin elicited by control and test foods/drinks Baseline
Secondary Fasting blood lipids (total, HDL and LDL cholesterol and triglycerides) Baseline and 4 weeks
Secondary Fasting C-reactive protein Baseline and 4 weeks
Secondary Fasting apolipoproteins A1 and B100 Baseline and 4 weeks
Secondary Body weight Weekly for 4 weeks
Secondary Waist circumference 4 weeks
Secondary Blood pressure 4 weeks
Secondary Symptoms 4 weeks
See also
  Status Clinical Trial Phase
Recruiting NCT04940962 - Translational Study Using Human Abdominal Adipose Tissue Biopsies to Investigate the Role of Cannabinoid Receptor 1 (CB1) in Controlling Endocannabinoid and Adipokine Secretion N/A
Completed NCT02194504 - The Belly Fat Study: Nutritional Intervention to Improve Metabolic Health in Subjects With Increased Abdominal Adiposity N/A
Completed NCT00520858 - Effects of Exercise Modality on Abdominal Obesity and Health Risk Factors in Older Men and Women N/A
Recruiting NCT03212391 - WAVE Study- Walking and Aging in VErona Study N/A
Completed NCT03898518 - The Effects of a Jump Rope Exercise Program on Body Composition and Self-efficacy in Obese Adolescent Girls N/A
Recruiting NCT04136717 - Influence of FreeO2 on Percentage of Time Within Oxygen Saturation Target Using Noninvasive Ventilation (NIV) and Continuous Positive Airway Pressure (CPAP) for Patients Admitted for AECOPD or Bariatric Surgery N/A
Completed NCT05413954 - To Evaluate the Health Effect of Particular Fatty Acids Profiles From Eggs N/A
Recruiting NCT05062954 - Effects of a Polyphenol-rich Cranberry Extract on Cardiometabolic and Neurocognitive Health N/A
Completed NCT01472666 - Dairy Lipids, Proteins, and the Metabolic Syndrome - "DairyHealth" N/A
Completed NCT00990457 - Evaluating the Effects Two Diets Combined With Exercise in Persons With Abdominal Obesity (The SHAPE5 Study) Phase 3
Completed NCT05685017 - Adiponectin, ICAM-1, VCAM-1 Levels and Metabolic Syndrome in Obese Adolescents
Completed NCT03773900 - Characterization of Gut Microbiota Composition and Activity After a Daily Supplementation of 4.5 g/Day of ChitinGlucan Fibre During 3 Weeks in At-cardiometabolic Risk Volunteers N/A
Completed NCT04635332 - Food Literacy and Physical Activity Intervention to Optimize Metabolic Health Among Women in Urban Uganda N/A
Completed NCT00739180 - Physical Activity in Youth: Implications for Reversing Risk Factors for Type 2 Diabetes N/A
Completed NCT00664729 - Diet, Exercise, Metabolism, and Obesity in Older Women N/A
Completed NCT03389425 - Application of the SIMPLE Program for Weight Loss at Pathways to Housing: A Feasibility Study N/A
Completed NCT05900843 - Weight Abnormalities With Diet and Exercise Frequency in Egyptian Children With Cerebral Palsy
Not yet recruiting NCT06376955 - High Intensity Interval Versus Focused Ultrasound on Insulin Resistance in Diabetics With Abdominal Obesity N/A
Recruiting NCT05879692 - Response of Irritable Bowel Syndrome to Abdominal Fat Reduction N/A
Completed NCT02931630 - The Effect of Whey Protein and Dietary Fibers on Risk Markers of the Metabolic Syndrome and Bone Health N/A